Nasopharyngeal carriage and transmission of Streptococcus pneumoniae in American Indian households after a decade of pneumococcal conjugate vaccine use

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Mosser, Jonathan F ^a   Grant, Lindsay R ^a   Millar, Eugene V ^b   Weatherholtz, Robert C ^a   Jackson, Delois M ^c   Beall, Bernard ^c   Craig, Mariddie J ^d   Reid, Raymond ^a   Santosham, Mathuram ^a   O'Brien, Katherine L ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d White Mountain Apache Tribe   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGE; AGED; AMERICAN INDIAN; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CHILD; COHORT ANALYSIS; DISEASE DURATION; FEMALE; HOUSEHOLD; HUMAN; INFECTION RISK; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PHARYNX DISEASE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADULT; CARRIER STATE; CHILD; CHILD, PRESCHOOL; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; LOGISTIC MODELS; MALE; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84898410897     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079578     Document Type: Article

References (39)

1. Shah SS, Ratner AJ (2006) Trends in invasive pneumococcal disease-associated hospitalizations. Clin Infect Dis 42(1):e1-5.
2. Lexau C, Lynfield R, Danila R, Pilishvili T, Facklam R, et al. (2005) Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294(16):2043-51. (Pubitemid 41539937)
3. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, et al. (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201(1):32-41.
4. Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, et al. (2008) Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Clin Infect Dis 47(4):476-84.
5. Isaacman DJ, McIntosh ED, Reinert RR (2010) Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 14(3):e197-209.
6. World Health Organization (2008) Estimated Hib and pneumococcal deaths for children under 5 years of age Available: http://www.who.int/immunization- monitoring/burden/Pneumo-hib-estimates/en/index.html. ccessed 6 December 2012.
7. Gray BM, Converse GM, Dillon HC (1980) Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 142(6):923-33. (Pubitemid 11153261)
8. Faden H, Duffy L, Wasielewski R, Wolf J, Krystofik D, et al. (1997) Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis 175(6):1440-1445. (Pubitemid 27225048)
9. Bogaert D, Groot RD, Hermans PWM (2004) Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet 4(March):144-154. (Pubitemid 38293138)
10. Leino T, Hoti F, Syrjänen R, Tanskanen A, Auranen K (2008) Clustering of serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day care centres. BMC Infect Dis 8:173.
11. Hill PC, Townend J, Antonio M, Akisanya B, Ebruke C, et al. (2010) Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin Infect Dis 50(11):1468-76.
12. Goldblatt D, Hussain M, Andrews N, Ashton L, Virta C, et al. (2005) Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis 192(3):387-93. (Pubitemid 41023116)
13. Melegaro A, Gay NJ, Medley GF (2004) Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol Infect 132(3):433-41. (Pubitemid 38714119)
14. Melegaro A, Choi Y, Pebody R, Gay N (2007) Pneumococcal carriage in United Kingdom families: estimating serotype-specific transmission parameters from longitudinal data. Am J Epidemiol 166(2):228-35. (Pubitemid 47227292)
15. Auranen K, Arjas E, Leino T, Takala AK (2000) Transmission of pneumococcal carriage in families: a latent Markov process model for binary longitudinal data. J Am Stat Assoc 95(452):1044.
16. Leino T, Auranen K, Jokinen J, Leinonen M, Tervonen P, et al. (2001) Pneumococcal carriage in children during their first two years: important role of family exposure. Pediatr Infect Dis J 20(11):1022-7. (Pubitemid 33055071)
17. Granat SM, Ollgren J, Herva E, Mia Z, Auranen K, et al. (2009) Epidemiological evidence for serotype-independent acquired immunity to pneumococcal carriage. J Infect Dis 200(1):99-106.
18. Hussain M, Melegaro A, Pebody RG, George R, Edmunds WJ, et al. (2005) A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect 133(5):891-8. (Pubitemid 41478975)
19. Millar EV, O'Brien KL, Watt JP, Bronsdon MA, Dallas J, et al. (2006) Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population. Clin Infect Dis 43(1):8-15. (Pubitemid 43939070)
20. Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, et al. (2008) Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis 47(8):989-96.
21. Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, et al. (2006) Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis 193(11):1487-94. (Pubitemid 43794576)
22. Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, et al. (2009) Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Pediatr Infect Dis J 28(11):990-5.
23. O'Brien KL, Millar EV, Zell ER, Bronsdon M, Weatherholtz R, et al. (2007) Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 196(8):1211-20. (Pubitemid 47580276)
24. Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, et al. (2010) Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease. Clin Infect Dis 50(9):1238-46.
25. Scott JR, Millar EV, Lipsitch M, Moulton LH, Weatherholtz R, et al. (2012) Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. J Infect Dis 205(2):280-8.
26. Millar EV, O'Brien KL, Zell ER, Bronsdon MA, Reid R, et al. (2009) Nasopharyngeal carriage of Streptococcus pneumoniae in Navajo and White Mountain Apache children before the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 28(8):711-6.
27. Millar EV, Pimenta FC, Roundtree A, Jackson D, Carvalho Mda G, et al. (2010) Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6C invasive disease and carriage within Navajo and White Mountain Apache communities. Clin Infect Dis 51(11):1258-65.
28. Mercado E, Srinivasan V, Hawkins P, Chochua S, Ochoa T, et al. (2011) First report of Streptococcus pneumoniae serotype 6D in South America. J Clin Microbiol 49(5):2080-1.
29. Melnick N, Thompson TA, Beall BW (2010) Serotype-specific typing antisera for pneumococcal serogroup 6 serotypes 6A, 6B, and 6C. J Clin Microbiol 48(6):2311-2.
30. StataCorp. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP, 2011.
31. Pinheiro JC, Bates DM (1995) Approximations to the log-likelihood function in the nonlinear mixed-effects model. J Comput Graph Stat 4:12-35.
32. Pinheiro JC, Chao EC (2006) Efficient Laplacian and adaptive Gaussian quadrature algorithms for multilevel generalized linear mixed models. J Comput Graph Stat 15:58-81. (Pubitemid 43514411)
33. Darboe MK, Fulford AJ, Secka O, Prentice AM (2010) The dynamics of nasopharyngeal Streptococcus pneumoniae carriage among rural Gambian mother-infant pairs. BMC Infect Dis 10:195.
34. Högberg L, Geli P, Ringberg H, Melander E, Lipsitch M, et al. (2007) Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J Clin Microbiol 45(3):948-52. (Pubitemid 46427716)
35. Hussain M, Melegaro A, Pebody RG, George R, Edmunds WJ, et al. (2005) A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect 133(5):891-8. (Pubitemid 41478975)
36. Tigoi CC, Gatakaa H, Karani A, Mugo D, Kungu S, et al. (2012) Rates of acquisition of pneumococcal colonization and transmission probabilities, by serotype, among newborn infants in Kilifi District, Kenya. Clin Infect Dis 55(2):180-8.
37. Grant LR, O'Brien SE, Burbidge P, Haston M, Zancolli M, et al. (2013) Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes. PLoS One 8: e74906.
38. Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P, et al. (2011) The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Vaccine 29(41):7207-11
39. Nuorti JP, Whitney CG (2010) Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 59(RR-11):1-18.